• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (10)
    • Molecular cloning of a rhodopsin gene from salamander rods.
    • Femoral Vein
    • Optimal design for the precise estimation of an interaction threshold: the impact of exposure to a mixture of 18 polyhalogenated aromatic hydrocarbons.
    • Exacerbation of posttraumatic stress disorder symptoms with medical illness.
    • Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator.
    • See All 10 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator.

Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator. J Stroke Cerebrovasc Dis. 2016 Nov; 25(11):2569-2574.

View in: PubMed

subject areas
  • Aged
  • Aged, 80 and over
  • Disability Evaluation
  • Female
  • Fibrinolytic Agents
  • Healthcare Disparities
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Patient Selection
  • Perfusion Imaging
  • Predictive Value of Tests
  • Recombinant Proteins
  • Registries
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Sex Factors
  • South Carolina
  • Stroke
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator
  • Tomography, X-Ray Computed

authors with profiles
  • Thomas Nathaniel